| CTRI Number |
CTRI/2024/08/072044 [Registered on: 07/08/2024] Trial Registered Prospectively |
| Last Modified On: |
06/08/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Bone health in women with premature menopause |
|
Scientific Title of Study
|
Multiparametric evaluation of bone health in women with premature ovarian insufficiency: A prospective cross-sectional study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vidushi Kulshrestha |
| Designation |
Additional Professor |
| Affiliation |
AIIMS New Delhi |
| Address |
Room No 725 7th Floor
Department of Obstetrics and Gynaecology
Mother and Child Block AIIMS New Delhi
South DELHI 110029 India |
| Phone |
9891910880 |
| Fax |
|
| Email |
drvidushi.kul@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pragya Shukla |
| Designation |
Junior Resident |
| Affiliation |
AIIMS New Delhi |
| Address |
Room No 725 7th Floor
Department of Obstetrics and Gynaecology
Mother and Child Block AIIMS New Delhi
South DELHI 110029 India |
| Phone |
8840614578 |
| Fax |
|
| Email |
pragyashukla07071998@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Pragya Shukla |
| Designation |
Junior Resident |
| Affiliation |
AIIMS New Delhi |
| Address |
Room No 725 7th Floor
Department of Obstetrics and Gynaecology
Mother and Child Block AIIMS New Delhi
South DELHI 110029 India |
| Phone |
8840614578 |
| Fax |
|
| Email |
pragyashukla07071998@gmail.com |
|
|
Source of Monetary or Material Support
|
| Research Section, AIIMS, New Delhi-110029
Intramural grant for financial support for Thesis grant wide letter with Reference No. F.No. 1-2/JR-SR-Thesis/2023/RS dated 22.02.2024 |
|
|
Primary Sponsor
|
| Name |
Research Section Thesis Grant AIIMS New Delhi |
| Address |
Research Section , AIIMS East Ansari Nagar New Delhi, PIN-110029 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pragya Shukla |
AIIMS New Delhi |
Room No 725, Department of Obstetrics and Gynaecology, Mother and Child block,
AIIMS, New Delhi South DELHI |
8840614578
pragyashukla07071998@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institute Ethics Committee for Post Graduate Research |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N912||Amenorrhea, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
None |
None |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
Subjects
Women with POI meeting all the following criteria
- Age less than 40 years
- Secondary amenorrhea for at least four months
- Elevated FSH 25.0 IU/L on two occasions at least 4 weeks apart
Controls
- Age and parity matched healthy women with normal menstrual cycles and serum FSH in normal range |
|
| ExclusionCriteria |
| Details |
Both subjects and controls
- History of surgery on tubes/ovaries, post radiation, post chemotherapy
- Any systemic illness, History of chronic renal disease
- Hyperthyroidism, hyperparathyroidism
- On corticosteroids and anticonvulsant therapy which are known to affect bone metabolism
- Unwilling to give written informed consent |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| BMD at the spine and hip, TBS, serum levels of Osteopontin, P1NP, Beta Cross Laps |
At baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
- Number of women with POI who have bone density scores less than one standard deviation below the mean of the reference group in spine and/or hip region
- Correlation of biomarkers levels with BMD & TBS
- Questionnaire to assess awareness of POI & its impact on bone. |
At baseline |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
20/08/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Primary ovarian insufficiency (POI) is the cessation of ovarian function before the expected age of menopause and is defined by oligo/amenorrhea for at least 4 months, and an elevated FSH level more than 25 IU/l on two occasions at least 4 weeks apart in women under the age of 40 years. POI has long term consequences. It affects bone health and leads to osteoporosis. Hence early detection is important to initiate treatment before POI affects the bone health. Primary objective of this study is to evaluate bone health in women with POI as assessed by multiple parameters of bone health including bone mineral density (BMD), Trabecular bone score (TBS) and serum biomarkers. Secondary objective of this study is to compare BMD, TBS and serum levels of P1NP, Osteopontin, Beta Cross Laps in women with POI with controls and to assess awareness of women for impact of POI on their bone health. |